Literature DB >> 11316854

Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples.

Bunyong Phakdeekitcharoen1,2, Terry J Watnick1, Gregory G Germino1.   

Abstract

The replicated portion of PKD1, which comprises nearly 70% of the length of the gene, is predicted to harbor at least 85% of the mutations present in affected autosomal dominant polycystic kidney disease type 1 pedigrees. The relative paucity of reported mutations involving this segment is attributable to the significant technical challenges posed by the genomic structure of the gene. Previous genomic DNA-based strategies were unable to evaluate exons 1 and 22 and relied on the use of 10- to 13-kb PCR products. In this report, a set of six novel primer pair combinations, which can be used with previously reported reagents to analyze all of the exons in the replicated region (exons 1 to 34), are described. No product is greater than 5.8 kb in length, and various primer combinations can be used to reduce this length in half. Using this approach, two new pathogenic mutations, four novel disease-associated missense substitutions, and six new normal variants were identified. These new reagents should prove useful to investigators interested in performing DNA testing for this disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316854     DOI: 10.1681/ASN.V125955

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  21 in total

Review 1.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

Review 2.  ADPKD: molecular characterization and quest for treatment.

Authors:  Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 3.  Molecular diagnostics for autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 4.  Diagnosis and screening of autosomal dominant polycystic kidney disease.

Authors:  York Pei; Terry Watnick
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

5.  Autosomal dominant polycystic kidney disease.

Authors:  York Pei; Terry Watnick
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

6.  A missense mutation in PKD1 attenuates the severity of renal disease.

Authors:  York Pei; Zheng Lan; Kairong Wang; Miguel Garcia-Gonzalez; Ning He; Elizabeth Dicks; Patrick Parfrey; Gregory Germino; Terry Watnick
Journal:  Kidney Int       Date:  2011-10-26       Impact factor: 10.612

7.  The nanomechanics of polycystin-1 extracellular region.

Authors:  Feng Qian; Wen Wei; Gregory Germino; Andres Oberhauser
Journal:  J Biol Chem       Date:  2005-10-11       Impact factor: 5.157

8.  Genetics and phenotypic characteristics of autosomal dominant polycystic kidney disease in Finns.

Authors:  Paula Peltola; Anne Lumiaho; Raija Miettinen; Jussi Pihlajamäki; Richard Sandford; Markku Laakso
Journal:  J Mol Med (Berl)       Date:  2005-03-17       Impact factor: 4.599

Review 9.  Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Authors:  Emilie Cornec-Le Gall; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

10.  Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease.

Authors:  Miguel A Garcia-Gonzalez; Jeffrey G Jones; Susan K Allen; Christopher M Palatucci; Sat D Batish; William K Seltzer; Zheng Lan; Erica Allen; Feng Qian; Xose M Lens; York Pei; Gregory G Germino; Terry J Watnick
Journal:  Mol Genet Metab       Date:  2007-06-18       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.